Ser259
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser259  -  NFAT3 (human)

Site Information
APGPtPAsPRPAsPC   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 31859079

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry ( 2 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
293 (epithelial) ( 1 ) , HaCaT (keratinocyte) ( 1 ) , HeLa (cervical) ( 2 )

Upstream Regulation
Kinases, in vitro:
CDK3 (human) ( 1 )

Downstream Regulation
Effects of modification on biological processes:
cell growth, induced ( 1 ) , transcription, induced ( 1 )

Disease / Diagnostics Relevance
Relevant diseases:
BCC ( 1 ) , melanoma skin cancer ( 1 ) , cancer, squamous cell carcinoma ( 1 )

References 

1

Xiao T, et al. (2017) Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer. Oncogene 36, 2835-2845
27893713   Curated Info

2

Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5
21712546   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.